What are the CD (Cluster of Differentiation) markers for Natural Killer (NK) cells?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CD Markers for Natural Killer (NK) Cells

Natural killer cells are identified by the expression of CD16 and/or CD56 in the absence of CD3, with the two major subsets being CD56bright CD16dim/- and CD56dim CD16+. 1

Primary NK Cell Markers

Essential Positive Markers

  • CD56 is the hallmark marker for NK cells, expressed on the majority of peripheral blood NK cells, though a CD56-negative subset exists 1
  • CD16 (FcγRIII) is expressed on most mature NK cells and mediates antibody-dependent cellular cytotoxicity (ADCC) 1
  • CD45 is brightly expressed on all NK cells, distinguishing them from other leukocytes with their characteristic low side-scatter properties 1

Essential Negative Markers

  • CD3-negative (surface CD3) is critical for distinguishing NK cells from T cells, though NK cells express cytoplasmic CD3ε 1
  • CD19/CD20-negative excludes B-cell lineage 1

Major NK Cell Subsets

CD56bright CD16dim/- Subset

  • Constitutes approximately 5-10% of peripheral blood NK cells but represents the majority in secondary lymphoid tissues 2
  • Functions primarily as cytokine producers (IFN-γ, TNF-α) with weak cytotoxic activity before activation 2
  • Expresses high levels of CD94, NKG2A, and lacks or has dim CD16 expression 2

CD56dim CD16+ Subset

  • Represents approximately 90% of peripheral blood NK cells 2
  • Highly cytotoxic with strong perforin and granzyme expression 2
  • Expresses killer immunoglobulin-like receptors (KIRs) for HLA class I recognition 3

CD56-negative CD16+ Subset

  • Constitutes approximately 5.67% of NK cells in healthy individuals but expands significantly during chronic viral infections (particularly HIV-1, increasing by mean difference of 10.69%) 4, 3
  • Expresses CD16b (FCGR3B), CD32A/B (FCGR2A/B), and has distinct cytotoxic mechanisms relying on ADCC and antibody-dependent respiratory burst 4
  • Shows higher expression of perforin 2 (MPEG1), HLA-DR, and PD-1, with lower expression of NKp46 (NCR1) and NKp80 (KLRF1) compared to CD56dim cells 4

Additional NK Cell Markers

Activation and Functional Markers

  • CD27 distinguishes NK cell maturation states: CD27hi correlates with CD56bright phenotype, while CD27lo correlates with CD56dim phenotype 5
  • CD57 marks terminally differentiated, highly cytotoxic NK cells with reduced proliferative capacity 6
  • CD94/NKG2A inhibitory receptor complex is expressed on immature NK cells 1
  • CD161 (NKR-P1A) is expressed on NK cells and some T cell subsets 6

Cytotoxic Granule Proteins

  • Perforin, granzyme B, and TIA1 are intracellular markers confirming cytotoxic capacity 1

Natural Cytotoxicity Receptors (NCRs)

  • NKp46 (CD335), NKp30, and NKp44 mediate natural cytotoxicity against tumor and infected cells 1, 4

Clinical Application in Flow Cytometry Panels

Standard NK Cell Identification Panel

  • Minimum panel: CD3/CD16/CD56 to identify CD3-CD56+ and/or CD3-CD16+ populations 1
  • Three-color panel: CD3/CD19/CD16 and/or CD56 to account for all lymphocyte lineages 1
  • Four-color panel: CD45/CD3/CD19/CD16 and/or CD56 for comprehensive lymphocyte gating 1

Important Technical Considerations

  • NK cells have bright CD45 fluorescence but slightly more side-scattering properties than the majority of lymphocytes, requiring careful gating to ensure inclusion 1
  • CD45/side scatter gates for lymphocytes should contain >95% lymphocytes to avoid contamination with monocytes or basophils 1
  • Strict flow cytometry gating strategy excluding monocytes is essential when identifying CD56-negative NK cells to avoid false-positive results 4

Quality Control

  • Monoclonal antibodies labeling T-cells (CD3), B-cells (CD19/CD20), and NK-cells (CD16/CD56) should account for all lymphocytes in the specimen 1
  • Validation of lymphocyte gates using T-, B-, and NK-cell markers is recommended to ensure proper inclusion of all NK cell subsets 1

Disease-Specific Considerations

NK/T-Cell Lymphomas

  • Typical NK-cell immunophenotype: CD20-, CD2+, cytoplasmic CD3ε+ (surface CD3-), CD4-, CD5-, CD7-/+, CD8-/+, CD43+, CD45RO+, CD56+, TCRαβ-, TCRγδ-, with EBV-EBER positivity 1
  • Cytotoxic granule proteins (TIA1, perforin, granzyme B) are usually expressed 1
  • TCR and immunoglobulin genes remain in germline configuration, confirming NK lineage 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.